Updated Notice of Annual General Meeting Mittwoch, 22. Oktober 2014 - 07:00
Press release
Updated Notice of Annual General Meeting
Tel Aviv/Zurich, 22 October 2014 - SHL Telemedicine Ltd. (SIX Swiss Exchange: SHLTN), a leading provider and developer of advanced personal telemedicine solutions, announced today that further to the notice of the Annual General Meeting published on October 13, 2014, which has set November 27, 2014 as the date for the Annual General Meeting of shareholders ("AGM") to be held at 10.00 a.m. (Israel Time) at the Company’s registered office, located at 90 Yigal Alon Street, Ashdar Building, Tel-Aviv, Israel and has set October 30, 2014 as the deadline for registration in the share register in order to participate and vote at the AGM, it is updating the agenda. The items at this year's AGM are:
1. | Presentation and discussion of the Company’s financial statements for the fiscal year ending December 31, 2013, as approved by the Board on March 24, 2014 |
2. | The re-appointment of Kost, Forer, Gabbay & Kasierer (members of Ernst & Young Global) as the external auditors of the Company for the fiscal year 2014 |
3. | Approval of Interested Party Engagement Terms |
4. | Approval of Director compensation and D&O indemnification undertaking |
5. | Election of Directors of which the proposed candidates are: Mr. Elon Shalev (Chairman), Mr. Yariv Alroy, Mr. Erez Alroy, Ms. Dvora Kimhi, Mr. Salomon Mizrahi, Mr. Eli Ayalon and Mr. Ziv Carthy (all of whom are currently serving as Board Members), as well as new candidates: Mr. Gary Sherne, Prof. Dan Oppenheim, Mr. Gur Shomron (if not elected as an independent (external) director), Mr. Amnon Sorek, Mr. Elad Magal and Mr. Oren Most, with Mr. Gary Sherne and Mr. Oren Most as Independent (Non-Dependent) Directors; and election of one new independent (external) director to the Board for a three year term. The current candidates are Mr. Gur Shomron and Dr. Ruth Ben Yakar. |
The related materials are available at www.shl-telemedicine.com/about-us/investorrelations/general-meeting/.
About SHL Telemedicine
SHL Telemedicine is engaged in developing and marketing personal telemedicine systems and the provision of medical call center services, with a focus on cardiovascular and related diseases, to end users and to the healthcare community. SHL Telemedicine offers its services and personal telemedicine devices to subscribers utilizing telephonic and Internet communication technology. The Company operates in Israel, Germany, India and the United States in one business segment, Telemedicine services. SHL is listed on the SIX Swiss Exchange (SHLTN, ISIN: IL0010855885, Security No.: 1128957) and has an ADR program listed over-the counter; Symbol: SMDCY. For more information please visit our web site at www.shl-telemedicine.com.
Contacts:
Erez Alroy Co-CEO P:+972 3 5612212, | Martin Meier-Pfister IRF Communications P: +41 43 244 81 40 | Garth Russell / Elizabeth Barker KCSA Strategic Communications P: 212-896-1250 / 212-896-1203 |
Some of the information contained in this press release contains forward-looking statements. Readers are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those in the forward-looking statements as a result of various factors. SHL Telemedicine undertakes no obligation to publicly update or revise any forward-looking statements.
